BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25277867)

  • 21. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.
    Hummel TR; Salloum R; Drissi R; Kumar S; Sobo M; Goldman S; Pai A; Leach J; Lane A; Pruitt D; Sutton M; Chow LM; Grimme L; Doughman R; Backus L; Miles L; Stevenson C; Fouladi M; DeWire M
    J Neurooncol; 2016 Mar; 127(1):53-61. PubMed ID: 26626490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas.
    Kilburn LB; Kocak M; Baxter P; Poussaint TY; Paulino AC; McIntyre C; Lemenuel-Diot A; Lopez-Diaz C; Kun L; Chintagumpala M; Su JM; Broniscer A; Baker JN; Hwang EI; Fouladi M; Boyett JM; Blaney SM
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 29090526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of positron emission tomography in the evaluation of diffuse intrinsic brainstem gliomas in children.
    Rosenfeld A; Etzl M; Bandy D; Carpenteri D; Gieseking A; Dvorchik I; Kaplan A
    J Pediatr Hematol Oncol; 2011 Jul; 33(5):369-73. PubMed ID: 21602725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploratory evaluation of MR permeability with 18F-FDG PET mapping in pediatric brain tumors: a report from the Pediatric Brain Tumor Consortium.
    Zukotynski KA; Fahey FH; Vajapeyam S; Ng SS; Kocak M; Gururangan S; Kun LE; Poussaint TY
    J Nucl Med; 2013 Aug; 54(8):1237-43. PubMed ID: 23801675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of (18)F-FDG PET to differentiate progressive disease from treatment induced necrosis in high grade glioma.
    Dankbaar JW; Snijders TJ; Robe PA; Seute T; Eppinga W; Hendrikse J; De Keizer B
    J Neurooncol; 2015 Oct; 125(1):167-75. PubMed ID: 26384811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T2-weighted images are superior to other MR image types for the determination of diffuse intrinsic pontine glioma intratumoral heterogeneity.
    Harward S; Harrison Farber S; Malinzak M; Becher O; Thompson EM
    Childs Nerv Syst; 2018 Mar; 34(3):449-455. PubMed ID: 29151166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in The Netherlands.
    Veldhuijzen van Zanten SE; Jansen MH; Sanchez Aliaga E; van Vuurden DG; Vandertop WP; Kaspers GJ
    Expert Rev Anticancer Ther; 2015 Feb; 15(2):157-64. PubMed ID: 25435089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffuse intrinsic pontine gliomas (DIPG) at recurrence: is there a window to test new therapies in some patients?
    Lobon-Iglesias MJ; Giraud G; Castel D; Philippe C; Debily MA; Briandet C; Fouyssac F; de Carli E; Dufour C; Valteau-Couanet D; Sainte-Rose C; Blauwblomme T; Beccaria K; Zerah M; Puget S; Calmon R; Boddaert N; Bolle S; Varlet P; Grill J
    J Neurooncol; 2018 Mar; 137(1):111-118. PubMed ID: 29198053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiparametric MR-PET Imaging Predicts Pharmacokinetics and Clinical Response to GDC-0084 in Patients with Recurrent High-Grade Glioma.
    Ellingson BM; Yao J; Raymond C; Nathanson DA; Chakhoyan A; Simpson J; Garner JS; Olivero AG; Mueller LU; Rodon J; Gerstner E; Cloughesy TF; Wen PY
    Clin Cancer Res; 2020 Jul; 26(13):3135-3144. PubMed ID: 32269051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brainstem gliomas in adults: prognostic factors and classification.
    Guillamo JS; Monjour A; Taillandier L; Devaux B; Varlet P; Haie-Meder C; Defer GL; Maison P; Mazeron JJ; Cornu P; Delattre JY;
    Brain; 2001 Dec; 124(Pt 12):2528-39. PubMed ID: 11701605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MR imaging assessment of tumor perfusion and 3D segmented volume at baseline, during treatment, and at tumor progression in children with newly diagnosed diffuse intrinsic pontine glioma.
    Sedlacik J; Winchell A; Kocak M; Loeffler RB; Broniscer A; Hillenbrand CM
    AJNR Am J Neuroradiol; 2013 Jul; 34(7):1450-5. PubMed ID: 23436052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular Drug Imaging:
    Jansen MH; Veldhuijzen van Zanten SEM; van Vuurden DG; Huisman MC; Vugts DJ; Hoekstra OS; van Dongen GA; Kaspers GL
    J Nucl Med; 2017 May; 58(5):711-716. PubMed ID: 27765855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET.
    Alger JR; Frank JA; Bizzi A; Fulham MJ; DeSouza BX; Duhaney MO; Inscoe SW; Black JL; van Zijl PC; Moonen CT
    Radiology; 1990 Dec; 177(3):633-41. PubMed ID: 2243962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural history and management of brainstem gliomas in adults. A retrospective Italian study.
    Salmaggi A; Fariselli L; Milanesi I; Lamperti E; Silvani A; Bizzi A; Maccagnano E; Trevisan E; Laguzzi E; Rudà R; Boiardi A; Soffietti R;
    J Neurol; 2008 Feb; 255(2):171-7. PubMed ID: 18293027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multimodal imaging-based classification for pediatric diffuse intrinsic pontine gliomas.
    Pan C; Zhang M; Xiao X; Kong L; Wu Y; Zhao X; Sun T; Zhang P; Geng Y; Zuo P; Wang Y; Li X; Gu G; Li T; Wu Z; Zhang J; Zhang L
    Neurosurg Rev; 2023 Jun; 46(1):151. PubMed ID: 37358632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria.
    Jansen MH; Veldhuijzen van Zanten SE; Sanchez Aliaga E; Heymans MW; Warmuth-Metz M; Hargrave D; van der Hoeven EJ; Gidding CE; de Bont ES; Eshghi OS; Reddingius R; Peeters CM; Schouten-van Meeteren AY; Gooskens RH; Granzen B; Paardekooper GM; Janssens GO; Noske DP; Barkhof F; Kramm CM; Vandertop WP; Kaspers GJ; van Vuurden DG
    Neuro Oncol; 2015 Jan; 17(1):160-6. PubMed ID: 24903904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging of adult brainstem gliomas.
    Purohit B; Kamli AA; Kollias SS
    Eur J Radiol; 2015 Apr; 84(4):709-20. PubMed ID: 25641008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progressive multifocal leukoencephalopathy (PML) mimicking high-grade glioma on delayed F-18 FDG PET imaging.
    Mertens K; Acou M; Van den Broecke C; Nuyts R; Van Roost D; Achten E; Goethals I
    J Clin Neurosci; 2012 Aug; 19(8):1167-9. PubMed ID: 22658241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. External validation of the diffuse intrinsic pontine glioma survival prediction model: a collaborative report from the International DIPG Registry and the SIOPE DIPG Registry.
    Veldhuijzen van Zanten SEM; Lane A; Heymans MW; Baugh J; Chaney B; Hoffman LM; Doughman R; Jansen MHA; Sanchez E; Vandertop WP; Kaspers GJL; van Vuurden DG; Fouladi M; Jones BV; Leach J
    J Neurooncol; 2017 Aug; 134(1):231-240. PubMed ID: 28560664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.